8-K - HeartSciences Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

HeartSciences Inc. reports the passing of COO, Corporate Secretary, and Board member Mark Hilz on April 1, 2026, with no plans to replace the COO role amid recent product milestones.

Key Takeaways

1Mark Hilz, Chief Operating Officer, Corporate Secretary, and Board member, passed away on April 1, 2026, at age 67 after illness.

2Hilz served on the Board since 2013 and as COO and Corporate Secretary since March 2022.

3Company does not anticipate hiring a new COO in the foreseeable future following MyoVista Insights launch and wavECG FDA submission.

4No expected changes to business, operations, or FDA commercialization plans due to Hilz's passing.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** (a)(b) On A

Management Change

Executive & Director Changes

Mark Hilz

Chief Operating Officer, Corporate Secretary, member of the Board of Directors

Passed away

Effective: 2026-04-01

following a period of illness

Exhibits (1)

8-K

CURRENT REPORT